Table 1.
All cases | CHD1L protein | ||
---|---|---|---|
Normal expression | Overexpression | ||
Normal ovaries | 30 | 30 (100%) | 0 (0) |
Cystadenomas | 35 | 33 (94%) | 2 (6%) |
Borderline tumors | 40 | 35 (87%) | 5 (13%) |
Invasive carcinomas | 160 | 75 (47%) | 85 (53%) |
a Values are n (%). A significant increasing frequency of intensive expression of CHD1L was observed in cystadenomas, in borderline tumors and in invasive carcinomas (P<0.01, Chi-Square Test for Trend).